• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

6.790 -0.130 (-1.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,684,974
Open 6.900
Bid (Size) 6.700 (100)
Ask (Size) 7.000 (1,000)
Prev. Close 6.920
Today's Range 6.660 - 7.000
52wk Range 2.540 - 9.600
Shares Outstanding 74,681,872
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
 
Via Benzinga
News headline image
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) Reports Narrower-Than-Expected Q2 2025 Loss, Shares Rise on Clinical Progress ↗
August 07, 2025
Corvus Pharmaceuticals reported a narrower Q2 2025 loss of $0.10 per share, beating estimates, with shares rising 5.8% after-hours. Positive Phase 1 data for soquelitinib in atopic dermatitis boosted... 
Via Chartmill

Performance

YTD
-7.2%
-7.2%
1 Month
-20.0%
-20.0%
3 Month
-2.0%
-2.0%
6 Month
+64.0%
+64.0%
1 Year
+27.4%
+27.4%

More News

Read More
News headline image
Corvus (CRVS) Q2 Loss Beats Estimates ↗
August 07, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
May 09, 2025
Via Benzinga
News headline image
Corvus Gets Price Target Hike From Oppenheimer On Positive Drug Trial Results: Retail’s Pleased ↗
May 09, 2025
Via Stocktwits
News headline image
Earnings Scheduled For May 8, 2025 ↗
May 08, 2025
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
November 12, 2024
Via Benzinga
News headline image
Why Is Corvus Pharmaceuticals Stock Soaring On Friday? ↗
May 09, 2025
Via Benzinga
News headline image
Wondering what's happening in today's pre-market session? ↗
May 09, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
May 09, 2025
Via Benzinga
News headline image
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
May 09, 2025
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
May 08, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
May 08, 2025
Via Benzinga
News headline image
These stocks are gapping in today's session ↗
March 26, 2025
Via Chartmill
News headline image
Corvus Pharma Stock Dips On Bigger-Than-Feared Q4 Loss, But Retail’s Faith Grows Stronger ↗
March 25, 2025
Via Stocktwits
News headline image
Earnings Scheduled For March 25, 2025 ↗
March 25, 2025
Via Benzinga
News headline image
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
January 02, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
December 18, 2024
Via Benzinga
News headline image
Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday? ↗
December 18, 2024
Via Benzinga
News headline image
Crude Oil Gains Over 1%, General Mills Shares Fall ↗
December 18, 2024
Via Benzinga
News headline image
Dow Surges 150 Points, US Current Account Deficit Widens In Q3 ↗
December 18, 2024
Via Benzinga
Topics Stocks
News headline image
Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
December 18, 2024
Via Benzinga
News headline image
US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak ↗
December 18, 2024
Via Benzinga
Topics Economy Stocks
News headline image
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗
December 18, 2024
Via Benzinga

Frequently Asked Questions

Is Corvus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Corvus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Corvus Pharmaceuticals, Inc. - Common Stock trade on?
Corvus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock is CRVS on the Nasdaq Stock Market
What is the current price of Corvus Pharmaceuticals, Inc. - Common Stock?
The current price of Corvus Pharmaceuticals, Inc. - Common Stock is 6.790
When was Corvus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Corvus Pharmaceuticals, Inc. - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock is 507.09M
How many shares of Corvus Pharmaceuticals, Inc. - Common Stock are outstanding?
Corvus Pharmaceuticals, Inc. - Common Stock has 507M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap